Kidnex IV

Wirkstoff: GINKGO, OXOGLURIC ACID, ANHYDROUS CITRIC ACID, FUMARIC ACID, MALIC ACID, PYRUVIC ACID, SUCCINIC ACID, SILVER, GOLD, COPPER, GERMANIUM SESQUIOXIDE, MERCURY, STRYCHNOS NUX-VOMICA SEED, PORK KIDNEY, SUS SCROFA LYMPH, 1,4-NAPHTHOQUINONE, SODIUM DIETHYL OXALACETATE, PHOSPHORUS, SUS SCROFA URINARY BLADDER, ACONITIC ACID, (Z)-

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · GINKGO 6 [hp_X]/mL, OXOGLURIC ACID 8 [hp_X]/mL, ANHYDROUS CITRIC ACID 8 [hp_X]/mL, FUMARIC ACID 8 [hp_X]/mL, MALIC ACID 8 [hp_X]/mL, PYRUVIC ACID 8 [hp_X]/mL, SUCCINIC ACID 8 [hp_X]/mL, SILVER 12 [hp_X]/mL, GOLD 12 [hp_X]/mL, COPPER 12 [hp_X]/mL, GERMANIUM SESQUIOXIDE 12 [hp_X]/mL, MERCURY 12 [hp_X]/mL, STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL, PORK KIDNEY 12 [hp_X]/mL, SUS SCROFA LYMPH 12 [hp_X]/mL, 1,4-NAPHTHOQUINONE 12 [hp_X]/mL, SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL, PHOSPHORUS 12 [hp_X]/mL, SUS SCROFA URINARY BLADDER 12 [hp_X]/mL, ACONITIC ACID, (Z)- 30 [hp_X]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Energique, Inc.

Geprüft 2026-10-09 · openFDA NDC